The leaders of major insulin makers and pharmacy benefit managers are set to blame each other on Wednesday in their testimonies during a U.S. Senate committee hearing on making the life-saving. | May 10, 2023
The leaders of major insulin makers and pharmacy benefit managers are set to point to causes of issues on Wednesday in their testimonies during a Senate committee hearing on making the life-saving drug more affordable.
By Ahmed Aboulenein WASHINGTON (Reuters) - The leaders of major insulin makers and pharmacy benefit managers (PBMs) are set to blame each other on Wed.
Leaders of major insulin
makers and pharmacy benefit managers traded blame for the
life-saving drug s high price on Wednesday while testifying at a
U.S. Senate committee hearing on making it more. | June 16, 2023